Federated Hermes, Inc. Biotechnology

Federated Hermes, Inc.

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
CRBU Caribou Biosciences, Inc.	$147M	$7,000 0.0% of portfolio	3,066	Q3 2025 Reduced 61.27%
LRMR Larimar Therapeutics, Inc.	$164M	$7,000 0.0% of portfolio	2,395	Q3 2025 Reduced 9.79%
NVAX Novavax Inc	$587M	$5,000 0.0% of portfolio	692	Q3 2025 New
ALXO Alx Oncology Holdings Inc	$63.2M	$4,000 0.0% of portfolio	2,374	Q3 2025 Reduced 63.71%
NVO Novo Nordisk A S	$109B	$4,000 0.0% of portfolio	80	Q3 2025 Reduced 99.77%
ATNM Actinium Pharmaceuticals, Inc.	$34.3M	$3,000 0.0% of portfolio	1,925	Q3 2025 Reduced 63.82%
FATE Fate Therapeutics Inc	$115M	$3,000 0.0% of portfolio	3,015	Q3 2025 New
TNGX Tango Therapeutics, Inc.	$693M	$3,000 0.0% of portfolio	362	Q2 2025 Reduced 95.23%
TCRX T Scan Therapeutics, Inc.	$21.6M	$3,000 0.0% of portfolio	2,181	Q2 2025 Reduced 0.05%
AGIO Agios Pharmaceuticals, Inc.	$2.2B	$2,000 0.0% of portfolio	53	Q3 2025 Reduced 91.12%
FULC Fulcrum Therapeutics, Inc.	$442M	$2,000 0.0% of portfolio	328	Q3 2025 New
URGN Uro Gen Pharma Ltd.	$460M	$2,000 0.0% of portfolio	132	Q3 2025 New
VRDN Viridian Therapeutics, Inc.\De	$895M	$2,000 0.0% of portfolio	132	Q3 2025 Added 10.92%
TBPH Theravance Biopharma, Inc.	$1.02B	$1,000 0.0% of portfolio	96	Q3 2025 New
ALT Altimmune, Inc.	$194M	$0 0.0% of portfolio	75	Q3 2025 Reduced 99.99%
CHRS Coherus Bio Sciences, Inc.	$124M	$0 0.0% of portfolio	479	Q3 2025 New
TGTX Tg Therapeutics, Inc.	$4.89B	$0 0.0% of portfolio	11	Q3 2025 Reduced 99.99%

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.